Sedative may prevent delirium in critically ill patients
A low dose of the sedative dexmedetomidine given at night may prevent delirium in critically ill patients, according to new research published online March 2, 2018 in the American Journal of Respiratory and Critical Care Medicine. Patients spent more days free of delirium in the ICU (8 vs 6 days) and also were less likely, if in pain, to experience severe pain (44% vs 66%).
To continue reading this article
Continue reading your article with a eMediNexus account.